Mustang Bio, Inc.
MBIO
$1.09
-$0.08-6.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -115.93% | -8.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -101.78% | -75.27% | |||
| Operating Income | 101.78% | 75.27% | |||
| Income Before Tax | 32.48% | 82.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 32.48% | 82.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 32.48% | 82.80% | |||
| EBIT | 101.78% | 75.27% | |||
| EBITDA | 105.48% | 74.92% | |||
| EPS Basic | 50.82% | 89.21% | |||
| Normalized Basic EPS | 104.70% | 84.05% | |||
| EPS Diluted | 50.82% | 89.21% | |||
| Normalized Diluted EPS | 104.70% | 84.05% | |||
| Average Basic Shares Outstanding | 37.30% | 59.31% | |||
| Average Diluted Shares Outstanding | 37.30% | 59.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||